XBI

SPDR® S&P Biotech ETF
NYSEARCA

Real-time Quotes | Provided by Morningstar

112.72
0.00
0.00%
Pre Market: 112.99 +0.27 +0.24% 09:05 09/23 EDT
OPEN
--
PREV CLOSE
112.03
HIGH
--
LOW
--
VOLUME
7.71K
TURNOVER
--
52 WEEK HIGH
121.06
52 WEEK LOW
62.94
TOTAL ASSET
5.61B
YTD YIELD
11.79%
1D
5D
1M
3M
1Y
5Y
News
Performance
The Daily Biotech Pulse: Coronavirus Vaccine Updates From J&J & MediciNova, Australian Regulatory Nod For GW Pharma
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 22)
Benzinga · 1h ago
Here's Why Healthcare Stocks Are Falling This Week
MotleyFool.com · 23h ago
The Daily Biotech Pulse: Legal Relief For Evolus, Fulgent to Join S&P SmallCap 600, AIM ImmunoTech's Positive Cancer Drug Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 21)
Benzinga · 1d ago
China ETFs Give Retail Investors Access to Soaring Tech, Ant
Bloomberg · 1d ago
SPDR S&P Biotech ETF declares quarterly distribution of $0.0890
SPDR S&P Biotech ETF (XBI) - $0.0890.30-Day SEC Yield of 0.17% as of Sept. 18.Payable Sep 24; for shareholders of record Sep 22; ex-div Sep 21.
Seekingalpha · 1d ago
Morgan Stanley Warns Nasdaq 100 May Fall More Than 20% From Peak
The tech-led selloff in U.S. equities is likely only halfway done, according to the Morgan Stanley strategist whose warning last month about the top-heavy market now appears prescient.
Bloomberg · 1d ago
This Week's Top Performing ETFs: 09/20/2020
ETF Database · 1d ago
At $5 Trillion, the ETF Market Is Showing Signs of Saturation
Bloomberg · 1d ago
More
No Data
Learn about the latest financial forecast of XBI. Analyze the recent business situations of SPDR® S&P Biotech ETF through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
Ratings
Date
Period
Agency
Ratings
08/31/2020
3 Year
Morningstar
08/31/2020
5 Year
Morningstar
08/31/2020
10 Year
Morningstar
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Month
-6.5522%
--
3-Month
2.3267%
--
6-Month
18.1541%
--
1-Year
11.7862%
--
3-Year
8.0603%
--
5-Year
8.1538%
--
10-Year
19.4995%
--
Since Inception
13.9739%
--
No Data
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
Profile
Fund Name
SPDR® S&P Biotech ETF
Risk
Low risk
Inception Date
2006-01-31
Benchmark
NASDAQ Composite CR
Advisor Company
State Street Global Advisors Ltd
Custodian
State Street Bank & Trust Co
Manager
Feehily/Schneider/Donofrio